INMUNE BIO INC. Income (Loss) from Continuing Operations before Income Taxes, Domestic
INMUNE BIO INC. (INMB) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of $35.76 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-03-30
- INMUNE BIO INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was $35.76M, a 58.22% increase from fiscal 2024.
- INMUNE BIO INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was $22.60M, a 11.42% increase from fiscal 2023.
- INMUNE BIO INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was $20.29M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month |
|---|---|
| 2025-12-31 | $35.76M 10-K · filed 2026-03-30 |
| 2024-12-31 | $22.60M 10-K · filed 2026-03-30 |
| 2023-12-31 | $20.29M 10-K · filed 2025-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |